Continuous glucose monitors (CGMs) are rapidly becoming an important tool for improving glycemic outcomes in diabetes. CGMs can potentially be used by hospitalized patients to sound alarms for impending hypoglycemia, inform insulin dosing, and provide an indicator of stress or well-being. Since the beginning of the COVID-19 pandemic in 2020, the FDA provided a policy to help expand the availability and capability of CGMs to facilitate patient monitoring while reducing patient and healthcare provider exposure to COVID-19. Interest in utilizing CGMs in the hospital has been stimulated by four trends in the application of CGM technology, including (1) improvements in the technology and human factors of CGMs, (2) an increasing number of patients wearing CGMs in ambulatory settings, (3) growing interest by clinicians to understand and interpret the glucose concentrations of hospitalized patients, and (4) an accumulation of published reports describing the use of these products in investigational settings. Diabetes Technology Society (DTS) organized the Continuous Glucose Monitor and Automated Insulin Dosing Systems in the Hospital Consensus Guideline Panel, which met virtually on April 23, 2020. The panelists voted for a consensus guideline containing 77 recommendations intended to support management of hospitalized patients with diabetes. Since then, many hospital clinicians have gained experience using CGMs for research studies or clinical care. DTS is now planning a virtual Hospital Diabetes Meeting for April 14-15, 2023 to review progress in the field of using CGMs in the hospital. This meeting will cover barriers and solutions to the use of this tool in various hospital settings as well as results of research abstracts. At this event, an international faculty of experts in the use of CGMs in the hospital will share their experiences, recommendations, and future plans.
Best regards,
David C. Klonoff, MD, FACP, FRCPE, Fellow AIMBE
President, Diabetes Technology Society
Virtual Hospital Diabetes Meeting
Welcome Letter
Dear Colleague,
It is our great pleasure to invite you to participate in the 2017 Virtual Hospital Diabetes Meeting that will be held from May 19-20, 2017, at the Georgia Tech Hotel and Conference Center in Atlanta, Georgia.
The field of diabetes technology has advanced rapidly over recent years and we now use innovative devices and systems for monitoring and caring for people with diabetes admitted to the hospital. Diabetes Technology Society now presents the Sixth Virtual Hospital Diabetes Meeting. A multi-disciplinary faculty of experts in hospital diabetes care will be discussing glycemic targets, insulin dosing, transitions of care, and the optimal use of current and future technologies for people with diabetes and hyperglycemia in both critical and non-critical care settings. Interactive workshops and comprehensive panel discussions will allow for close communication with these experts.
We look forward to meeting you in Atlanta.
Best Regards,
Guillermo Umpierrez, MD, FACE, CDE
Co-Chair, Virtual Hospital Diabetes Meeting Planning Committee
Emory University, Atlanta, Georgia
Jane Jeffrie Seley, DNP, MPH, BC-ADM, CDE, CDTC
Co-Chair, Virtual Hospital Diabetes Meeting Planning Committee
New York-Presbyterian/Weill Cornell, New York, New York
Amisha Wallia, MD, MS
Co-Chair, Virtual Hospital Diabetes Meeting Planning Committee
Northwestern Medical Group, Chicago, Illinois
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Co-Chair, Virtual Hospital Diabetes Meeting Planning Committee
Mills-Peninsula Medical Center, San Mateo, California